Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Watchful Waiting × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 4 Colonic Neoplasms 3 Uterine Cervical Neoplasms 2 Uterine Cervical Dysplasia 2 Triple Negative Breast Neoplasms 2 Oropharyngeal Neoplasms 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Ureteral Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Retinoblastoma 1 Rectal Neoplasms 1 Precancerous Conditions 1 Pleuropulmonary blastoma 1 Pelvic Neoplasms 1 Papillomavirus Infections 1 Neuroblastoma 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1

Interventions

Rituximab 19 Cyclophosphamide 13 Lenalidomide 10 zanubrutinib 8 fludarabine 8 venetoclax 5 fludarabine phosphate 5 pirtobrutinib 4 orelabrutinib 4 Vincristine 4 obinutuzumab 3 Whole-Body Irradiation 3 Specimen Handling 3 Prednisone 3 Magnetic Resonance Spectroscopy 3 Doxorubicin 3 CT-P10 3 ibrutinib 2 Therapeutics 2 Radiation 2 Mycophenolic Acid 2 Maintenance 2 Leukapheresis 2 Immunotherapy, Adoptive 2 Granulocyte Colony-Stimulating Factor 2 Cyclosporine 2 Biopsy 2 Bendamustine Hydrochloride 2 voruciclib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡